Codes / ICD10CM / T38.0X2S

T38.0X2S Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, sequela

Summary

This condition represents the residual effects of intentional self-harm involving glucocorticoids or their synthetic analogues. It is a sequela, meaning it describes complications or conditions resulting from a prior episode of poisoning. Glucocorticoids are medications used for anti-inflammatory and immunosuppressive purposes, and intentional self-harm may involve deliberate overdose or misuse of these agents.

Causes

Intentional self-harm by glucocorticoids typically results from deliberate ingestion or administration of these medications in excess of prescribed or safe doses. This may involve taking multiple doses at once, consuming medication not intended for the individual, or using these agents in a manner inconsistent with therapeutic guidelines. The sequela arises from the aftermath of such an event.

Risk Factors

  • History of mental health conditions (e.g., depression, anxiety)
  • Access to glucocorticoid medications in the home or healthcare setting
  • Prior episodes of self-harm or suicidal behavior
  • Social or environmental stressors contributing to intentional misuse

Symptoms

Symptoms may include metabolic disturbances (e.g., hyperglycemia, electrolyte imbalances), gastrointestinal upset, mood changes, or cardiovascular effects. Severity depends on the dose and individual sensitivity, with potential for severe toxicity in high-intake scenarios. Sequela may involve long-term effects such as organ damage or chronic metabolic issues.

Diagnosis

Diagnosis relies on a detailed patient history, clinical assessment of residual symptoms, and laboratory tests to evaluate metabolic or organ function. Documentation should link the current condition to the prior episode of intentional self-harm involving glucocorticoids.

Treatment Options

Treatment focuses on managing residual symptoms and preventing further harm. This may include monitoring for metabolic imbalances, providing supportive care, and addressing underlying mental health concerns. Long-term management may involve medication adjustments or rehabilitation.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the effectiveness of subsequent care. Follow-up care is essential to monitor for complications, address mental health needs, and ensure adherence to treatment plans. Regular assessments help track recovery and adjust interventions as needed.

Complications

Complications may include chronic organ damage, persistent metabolic disorders, or recurrent self-harm. Long-term effects can vary based on the extent of the initial poisoning and individual health factors.

Lifestyle & Prevention

Prevention strategies include secure storage of medications, education on proper use, and addressing mental health concerns. Supportive measures, such as counseling or therapy, may reduce the risk of future self-harm episodes.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning recur or worsen, or if there are signs of new or worsening complications. Mental health support should be sought if there are thoughts of self-harm or emotional distress.

Tips for Medical Coders

Use this code for sequela of intentional self-harm by glucocorticoids or synthetic analogues. Ensure documentation clearly links the current condition to the prior poisoning event. Code T38.0X2S is specific to sequela and should not be used for acute episodes. Verify that the intent (intentional self-harm) and the nature of the agent (glucocorticoids) are accurately documented.

Book a walkthrough

T38.0X2S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.